Bilandzic, Maree <br/><br/>
Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.  [electronic resource] 

 -  Molecular endocrinology (Baltimore, Md.)  Mar 2013 
 - 466-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-9917 
<br/><br/><label>Standard No.: </label>10.1210/me.2012-1239  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Cell Line, Tumor<br/>Cell Survival<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Female<br/>Granulosa Cell Tumor--enzymology<br/>Humans<br/>Models, Biological<br/>NF-kappa B--antagonists & inhibitors<br/>Proteoglycans--metabolism<br/>Receptors, Transforming Growth Factor beta--metabolism<br/>Signal Transduction<br/>Smad Proteins--metabolism<br/>Transforming Growth Factor beta2--metabolism